TY - JOUR
T1 - Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.
AU - Meaney-Delman, Dana
AU - Zotti, Marianne E.
AU - Creanga, Andreea A.
AU - Misegades, Lara K.
AU - Wako, Etobssie
AU - Treadwell, Tracee A.
AU - Messonnier, Nancy E.
AU - Jamieson, Denise J.
AU - Workgroup on Anthrax in Pregnant, on Anthrax in Pregnant
PY - 2014/2
Y1 - 2014/2
N2 - In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax.
AB - In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax.
UR - http://www.scopus.com/inward/record.url?scp=84899875704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899875704&partnerID=8YFLogxK
U2 - 10.3201/eid2002.130611
DO - 10.3201/eid2002.130611
M3 - Article
C2 - 24457117
AN - SCOPUS:84899875704
VL - 20
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
SN - 1080-6040
IS - 2
ER -